Birth Defects Marked End of Mammoths

New research suggests that the wooly beasts may have succumbed to a shrinking gene pool or intense environmental pressures as their species went extinct.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Is the presence of cervical ribs (arrow, inset) a clue to mammoth extinction?INSET FROM PEERJ PAPER - DOI: 10.7717/peerj.318/fig-1, WIKIMEDIA, FLICKR - TRACY OThe last remaining populations of wooly mammoths roaming the Earth as their species spiraled toward extinction about 10,000 years ago was beset with birth defects, perhaps the result of inbreeding or increased levels of prenatal stress caused by starvation or disease, according to a new study published in PeerJ yesterday (March 25). Dutch and Belgian researchers reported finding several fossil vertebrae near the North Sea in Europe that showed signs of cervical ribs, birth defects that can be a sign of widespread and serious developmental disturbances. “We knew these were just about the last mammoths living there, so we suspected something was happening,” study leader Jelle Reumer of Utrecht University in the Netherlands told LiveScience. “Our work now shows that there was indeed a problem in this population.”

Those so-called “neck ribs” were likely the result of inbreeding between shrunken populations of the imperiled creatures, of maternal stress brought on by dwindling resources or disease, or both, the scientists suggested. “Cervical ribs indicate there has been a disturbance of early pregnancy,” coauthor Frietson Galis, a paleontologist at the Naturalis Biodiversity Center in Leiden, the Netherlands, told Science.

Of the nine mammoth vertebrae that Reumer and his colleagues were able to analyze, the researchers found evidence of cervical ribs in three. The team also analyzed 28 elephant vertebrae from museums. Only one of those speciments showed evidence of a cervical rib. “This seemed [to be] an extremely high incidence,” Reumer told Science.

Researchers have long debated which factors—overhunting by humans, habitat shrinkage, or climate ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies